Self-Injurious Behavior Clinical Trial
Official title:
A Randomized 3-Month, Parallel-Group, Controlled Trial of CALMA M-Health App as an Adjunct to Therapy for the Reduction of Suicidal and Non-Suicidal Self-Injurious Behaviors in Adolescents
NCT number | NCT05453370 |
Other study ID # | 884 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | February 24, 2022 |
Est. completion date | January 2024 |
Suicide in the second cause of death in subjects between 15 and 24 years of age. Despite the efficacy of interventions for the management of suicidal crises observed in some clinical trials, a crucial aspect for their effectiveness is accessibility. This leaves little time to intervene during the suicidal process. New platforms to provide evidence-based interventions, universally, economically, and quickly are needed. Smartphones appear to be a good alternative considering the high penetration of these devices locally. The research group carried out a pilot randomized controlled cluster trial with four weeks of follow-up that provided initial evidence on the safety and acceptability of the app for reducing self-injurious thoughts and behaviors when used as an adjunct to conventional Dialectical Behavioral Therapy (DBT). This study conducted with a group of patients who were already undergoing DBT treatment program, and have shown good acceptability of CALMA as an adjunct to therapy targeting suicidal and non-suicidal self-injury behaviors. Although effectiveness was not the main outcome, results revealed a high probability to decrease suicidal outcomes including ideation, suicidal behaviors, Non-Suicidal Self-Injury (NSSI) and thoughts about NSSI in the group that received CALMA compared to the comparison group. No specific app for adolescents and young people is available in Spanish. The research group developed CALMA (the Spanish word for "calm"), the first user-interactive mobile app in Spanish. It provides evidence-based tools to manage a suicidal or non-suicidal self-directed violence crisis. CALMA also interacts with the user between crises by promoting activities that reduce their vulnerability to suicide by provide psychoeducation about suicide and its prevention. Based on these encouraging initial findings, in this project the investigators propose to scale the intervention to a larger group of patients, focus it on adolescents and including public hospitals not specialized in DBT. This is a parallel group, two-arm randomized controlled trial design, which will employ an intervention condition (CALMA app) and a control condition (Treatment as usual) with a 3-month follow-up for each participant, to evaluate the effectiveness, safety and acceptability of CALMA, a suicide prevention app for smartphones, to reduce the frequency of self-injurious thoughts and behaviors in adolescents who are assisted in a Mental Health service of three Public Hospitals.
Status | Recruiting |
Enrollment | 58 |
Est. completion date | January 2024 |
Est. primary completion date | January 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 10 Years to 19 Years |
Eligibility | Inclusion Criteria: - Patients from 10 to 19 years old who come on an outpatient basis or have been hospitalized in Mental Health Services - Have a smartphone where the application can be installed and used are eligible to participate in the study - Have attempted suicide, or exhibited a suicidal gesture or self-injurious behavior (according to the SITBI definition) in the last month before entering the study - Agree to give their informed consent and their guardian agrees to sign your informed consent Exclusion Criteria: - If the participant plans not to continue the treatment in the next 3 months or - Has an inability to provide assent/consent for cognitive or language reasons - Do not have the functional capacity to use the application, which will be operationally determined by a score below 30 on the Self-Care motor domain, below 10 on the Communication cognitive domain or below 14 on the Cognitive domain of Social Knowledge in the Functional Independence Measurement scale (FIM). |
Country | Name | City | State |
---|---|---|---|
Argentina | Institute of Pharmacology of the School of Medicine of the University of Buenos Aires | City of Buenos Aires | Buenos Aires |
Argentina | Pedro de Elizalde Children's General Hospital | City of Buenos Aires | Buenos Aires |
Argentina | Children's Hospital "Sor María Ludovica" | La Plata | Buenos Aires |
Argentina | Interzonal Acute Hospital "San Roque" de Gonnet | La Plata | Buenos Aires |
Lead Sponsor | Collaborator |
---|---|
University of Buenos Aires |
Argentina,
Daray FM, Olivera Fedi RH, Rodante DE. [Development of CALMA: A mobile APP for the prevention of suicide in adolescents and youth]. Vertex. 2018 Jan;29(137):55-64. Spanish. — View Citation
Rodante DE, Kaplan MI, Olivera Fedi R, Gagliesi P, Pascali A, Jose Quintero PS, Compte EJ, Perez AI, Weinstein M, Chiapella LC, Daray FM. CALMA, a Mobile Health Application, as an Accessory to Therapy for Reduction of Suicidal and Non-Suicidal Self-Injured Behaviors: A Pilot Cluster Randomized Controlled Trial. Arch Suicide Res. 2022 Apr-Jun;26(2):801-818. doi: 10.1080/13811118.2020.1834476. Epub 2020 Oct 18. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Time (days) to psychiatric admission | At follow-ups and at the final interview, participants will be asked if they have had a psychiatric hospitalization for a self-injurious behavior during the follow-up period. This measure will be used to compare time to psychiatric admission in those participants who received the intervention with those participants who did not receive the app. | from the date of enrollment to the date of the first psychiatric hospitalization for a self-injurious behavior up to 3 months. Participants will be assessed at the three follow-up timepoints: day-30, day-60, and day-90. | |
Other | Sociodemographic variables | Sociodemographic variables are: age, sex, gender, sexual orientation, education level and treatment modality (outpatient/inpatient). | Participants will be assessed at day-0 (baseline). | |
Primary | Change in Frequency of Suicidal and Non-Suicidal Self-Injurious Behaviors. | Suicidal behavior will be assessed using the Spanish version of the Self-Injurious Thoughts and Behaviors Interview (SITBI). This is a structured interview consisting of 169 items divided into 5 modules that examine the presence, frequency and characteristics of 5 types of self-injurious behavior: a) suicidal ideation; b) suicide plans; c) suicidal gestures; d) suicide attempts and e) self-harm. The SITBI conceptualizes suicide risk on a continuum, starting with suicide ideation (SI) ("thoughts of killing yourself?"), possibly accompanied by a suicide plan ("think about how you might kill yourself [e.g., taking pills, shooting yourself] or work out a plan of how to kill yourself?") and in some cases by suicide attempt (SA) ("made a suicide attempt [i.e., purposefully hurt yourself with at least some intent to die]?"). The construction of the questions in the original SITBI are consistent with the commonly accepted definitions of each type of behavior. | Participants will be assessed at four timepoints: day-0 (baseline), day-30, day-60 and day-90. | |
Secondary | Levels of Emotional Dysregulation | Emotional dysregulation will be quantified with the Spanish version of the Emotional Regulation Difficulties Scale (DERS). It has 36 items with a Likert-type response format (from 1 = almost never to 5 = almost always) and a six-factor structure: 1) Impulse control difficulties; 2) Limited access to emotional regulation strategies; 3) Non-acceptance of emotional responses; 4) Difficulty engaging in goal-directed behavior; 5) Lack of emotional awareness; 6) Lack of emotional clarity. The DERS has previously been used in pre- and post-intervention studies as an emotional dysregulation state variable to assess effectiveness. This variable has eleven reverse-scored items and will be considered as a quantitative variable (minimum value = 80; maximum value = 136). Higher scores suggest greater problems with emotion regulation. | Participants will be assessed at two timepoints: day-0 (baseline) and day-90. | |
Secondary | Levels of Engagement of the app. | The use of the app will be obtained and recorded via an objective measure recorded from the participant's phone number. Specifically, use will be considered when at least one of the following features of CALMA is used during the study period: opened a "Tips", arrived at the "Emergency Card", finished a crisis (due to success or abandonment), opened a notification, added a contact, reviewed their "Moments", added a picture or content to their "Moments", closed the app while it was in crisis and ended a crisis successfully. Patients will be defined as "users" of the app if they met the following criteria: subjectively reported using the app in the survey and used at least one feature recorded by our objective measures. | Participants will be assessed at three timepoints: day-30, day-60, and day-90. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02914847 -
Imaginator: a Pilot of Brief Functional Imagery Training for Self-harm
|
N/A | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT00491478 -
Repetitive Behavior Disorders in People With Severe Mental Retardation
|
Phase 3 | |
Terminated |
NCT02483572 -
Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control
|
N/A | |
Completed |
NCT02985047 -
Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide
|
N/A | |
Recruiting |
NCT04463654 -
Zero Self-Harm - a Mobile Phone Application to Reduce Non-suicidal Self-injury
|
N/A | |
Completed |
NCT04244786 -
Treating Self Injurious Behavior: A Novel Brain Stimulation Approach
|
N/A | |
Not yet recruiting |
NCT02595164 -
Common Decision Making Deficits in Suicidal Behaviors and Eating Disorders
|
N/A | |
Completed |
NCT00401102 -
Interpersonal Psychotherapy for Depressed Adolescents Engaging in Non-suicidal Self-injury
|
Phase 1 | |
Recruiting |
NCT06110585 -
Transcranial Magnetic Stimulation in Patients With Depression and Non-suicidal Self-injury
|
N/A | |
Completed |
NCT05563324 -
Genetics of Self-injurious Behaviour
|
||
Recruiting |
NCT04045600 -
Refinements of Functional Communication Training
|
N/A | |
Recruiting |
NCT00694668 -
The (Cost-) Effectiveness of Mindfulness-training and Cognitive Behavioural Therapy in Adolescents and Young Adults With Deliberate Self Harm
|
Phase 2/Phase 3 | |
Recruiting |
NCT05796531 -
Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization
|
N/A | |
Terminated |
NCT01823120 -
Text Message Intervention to Reduce Repeat Self-harm
|
N/A | |
Recruiting |
NCT00169884 -
The Efficacy of a Cognitive-Behavioural Intervention in Deliberate Self-Harm Patients
|
Phase 2 | |
Terminated |
NCT03980366 -
Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders
|
N/A | |
Not yet recruiting |
NCT05969080 -
Self-Injury Treatment and Recovery in Veterans
|
N/A | |
Recruiting |
NCT06225661 -
Focused Suicide Prevention Strategy for Youth Presenting to the Emergency Department With Suicide Related Behaviour
|
N/A | |
Enrolling by invitation |
NCT03995966 -
A Clinical Trial for Self-Injurious Behavior
|
N/A |